U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685873) titled 'Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease' on June 29.
Brief Summary: To evaluate the potential usefulness of 18F-FPyCO/SMBT-1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various MAO-B-related disease patients.
Study Start Date: June 25
Study Type: OBSERVATIONAL
Condition:
Parkinson Disease
Parkinson Disease Dementia
Parkinson's Disease and Parkinsonism
Intervention:
DIAGNOSTIC_TEST: Diagnostic Test: 18F-FPyCO/SMBT-1
Each subject receive a single intravenous injection of 18F-FPyCO/SMBT-1, and undergo PET/ CT or MRI imaging within the specifi...